This is an online event.
The Institute for Molecular Science and Engineering (IMSE) invites you to their Dr Theo George Wilson Annual Lecture: : Molecular Engineering in Translating potential into progress – COVID-19 Vaccines by Prof Teresa Lambe. Professor Teresa Lambe is a Principal Investigator/Group leader based at the Jenner Institute at the University of Oxford. She has been at the forefront of the development of the Oxford–AstraZeneca COVID-19 vaccine.
After the annual lecture there will also be a chance to view an intimate “online fireside discussion” with Professor Teresa Lambe and a few other Imperial experts. This will be an informal discussion about the topic where the panel will take a few key questions.
- 17.15 – Brief IMSE Introduction by Professor Amparo Galindo (IMSE Co-Director)
- 17.20 – Annual Lecture presented by Professor Teresa Lambe OBE
- 18.00 – Annual Lecture Q&A
- 18.10 – Online Fireside Discussion Chaired by Professor Nicholas Harrison (IMSE Co-Director)
- 18.40 – Event ends
About the speaker
Professor Teresa Lambe OBE is an Irish scientist working at Oxford University’s Jenner Institute. She is one of the co-developers of the Oxford–AstraZeneca COVID-19 vaccine against the new coronavirus causing COVID-19. Teresa Lambe is a Principal Investigator/Group leader based at the Jenner Institute.
Prof Lambe’s research investigates the establishment of protective immune responses following vaccination and the formation of adaptive immune memory. She is particularly interested in delineating the immune response post vaccination and also post natural infection to help develop vaccines and define correlates of protection. At the University of Oxford, her group uses platform technologies to develop vaccines against emerging and re-emerging pathogens. The group is currently developing vaccines against a number of outbreak pathogens including Crimean-Congo haemorrhagic fever virus, Lassa virus, Nipah virus, Influenza, Ebolavirus and coronaviruses.
Online Fireside Discussion Participants
Professor James Moore Jr ,The Bagrit & RAEng Chair in Medical Device Design, Department of Bioengineering, Imperial College London. Dr. Moore’s research interests include Cardiovascular Biomechanics, Stents, Implantable Devices, Atherosclerosis, and the Lymphatic System. His research focuses on the role of biomechanics in the formation and treatment of diseases such as atherosclerosis and cancer.
Dr. Zoltán Kis, Lecturer at the Department of Chemical and Biological Engineering at The University of Sheffield. Zoltán is developing and modelling rapid-response vaccine production platform technologies, such as the RNA platform. This work is addressing the challenge of producing large volumes of vaccines, rapidly, at high quality and at low cost for pandemic-response.
Dr. Maria Papathanasiou, Lecturer in the Department of Chemical Engineering Imperial College London. Dr. Maria Papathanasiou’s lab focuses on the adaptation of Industry 4.0 principles in (bio-) pharmaceutical processes. They work on the development of digital twins and control methodologies for process understanding, optimisation and automation.
The Institute for Molecular Science and Engineering (IMSE) is one of Imperial College London’s Global Institutes, drawing on the strength of its four faculties to address some of the grand challenges facing the world today. The Institute’s activities are focused on tackling problems where molecular innovation plays an important role.
If you have any questions about accessibility requirements please email Leah Adamson (IMSE Events Officer) on email@example.com